1. Home
  2. WVE vs NEOG Comparison

WVE vs NEOG Comparison

Compare WVE & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Neogen Corporation

NEOG

Neogen Corporation

N/A

Current Price

$9.46

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
NEOG
Founded
2012
1981
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
WVE
NEOG
Price
$13.35
$9.46
Analyst Decision
Strong Buy
Buy
Analyst Count
15
4
Target Price
$31.47
$10.67
AVG Volume (30 Days)
2.2M
2.5M
Earning Date
01-01-0001
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
$3,704,000.00
$894,661,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$119.93
$1.67
P/E Ratio
N/A
$109.67
Revenue Growth
149.43
N/A
52 Week Low
$5.28
$3.87
52 Week High
$21.73
$11.43

Technical Indicators

Market Signals
Indicator
WVE
NEOG
Relative Strength Index (RSI) 47.54 35.08
Support Level $12.53 $8.93
Resistance Level $14.56 $10.30
Average True Range (ATR) 0.79 0.41
MACD 0.01 -0.25
Stochastic Oscillator 23.84 13.97

Price Performance

Historical Comparison
WVE
NEOG

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

Share on Social Networks: